Parliamentarians and Civil Society African Dialogue on the Urgency to #ProtectTheCure and Address Malaria Resistance

Source(s):

Collaborator(s): Temple University, United States; World Health Organization (WHO), Switzerland; Roll Back Malaria (RBM) Partnership to End Malaria, Switzerland; Medicines for Malaria Venture (MMV), Switzerland; Civil society For Malaria Elimination (CS4ME), Cameroon

Published: 27/01/2026

As antimalarial drug resistance continues to emerge as a threat, this webinar offered a timely space to connect evidence, leadership, and action.

The Parliamentarians and Civil Society African Dialogue on the Urgency to #ProtectTheCure brought together experts and decision-makers to discuss:

what current data tell us about malaria drug resistance in Africa,
how political leadership and parliamentary oversight can help safeguard treatments,
why community engagement and accountability are essential, and
what concrete steps can be taken now to prevent a reversal of hard-won gains.

The dialogue featured contributions from:

The World Health Organization (WHO), including insights from the World Malaria Report 2025
RBM Partnership to End Malaria and Medicines for Malaria Venture (MMV) on coordination and innovation
African parliamentarians from the Coalition of Parliamentarians to End Malaria in Africa (COPEMA)
Researchers and civil society leaders from Global Civil Society for Malaria Elimination (CS4ME), working at the country and regional level